Rejection prophylaxis with antilymphocyte globulin for cardiac transplantation in Oriental recipients.
Wei
J
J
Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Chang
C Y
CY
Lee
F Y
FY
Song
Y B
YB
Jiau
S F
SF
D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007668:Kidney / Q000098:blood supply / Q000502:physiology; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D012039:Regional Blood Flow; D013601:T-Lymphocytes / Q000276:immunology; D013624:Taiwan
D000961:Antilymphocyte Serum; D016572:Cyclosporine